Mail

"It is disingenuous, at best, to infer that the WARF patents are part of a "racket," which suggests that these patents may be illegal. They are not." Stem cell patent wars Re: "End this Stem Cell Racket"1 and "Working with Stem Cells? Pay Up"2: The novelty of claim one in Thompson's (WARF) patent is not in parts (i) through (iii), but in the final clause: "is inhibited from differentiation when cultured on a fibroblast feeder layer." Is it not possible to inhibit


Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Re: "End this Stem Cell Racket"1 and "Working with Stem Cells? Pay Up"2: The novelty of claim one in Thompson's (WARF) patent is not in parts (i) through (iii), but in the final clause: "is inhibited from differentiation when cultured on a fibroblast feeder layer." Is it not possible to inhibit from differentiation using other techniques than a fibroblast feeder layer (e.g., see US Patent No. 6,800,480)? New approaches such as this one have been addressed not only because of Thompson's '806 patent, but because of the presence of impurities (such as viruses) in the feeder cells. If the non-feeder cell techniques do not work and using a fibroblast feeder layer is truly novel, then the patent is probably worth its reputed $400,000 license.

Further, the patent covers cells isolated from the blastocyst stage; cells derived either prior to or after the blastocyst stage may not be covered. For a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio